- Report
- April 2023
- 105 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- February 2024
- 180 Pages
Global
From €4522EUR$4,969USD£3,877GBP
- Report
- December 2021
- 44 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- July 2023
- 332 Pages
United States
From €7276EUR$7,995USD£6,238GBP
- Book
- March 2019
- 648 Pages
- Book
- November 2018
- 1088 Pages
- Book
- May 2013
- 424 Pages
- Book
- March 2009
- 516 Pages
- Book
- November 2024
North America
Dysmenorrhea, also known as painful periods, is a common condition experienced by women during menstruation. It is characterized by cramping, abdominal pain, and other symptoms such as nausea, vomiting, and diarrhea. Dysmenorrhea can range from mild to severe and can have a significant impact on a woman's quality of life. Treatment options for dysmenorrhea include lifestyle modifications, medications, and alternative therapies.
The dysmenorrhea market is an important part of the women's health industry. It is estimated that up to 90% of women experience some form of dysmenorrhea, making it a major concern for many. Companies in the dysmenorrhea market are focused on providing treatments and solutions to help women manage their symptoms. These include pharmaceutical companies, medical device manufacturers, and healthcare providers.
Some of the companies in the dysmenorrhea market include Bayer AG, Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, and Allergan plc. These companies offer a variety of products and services to help women manage their dysmenorrhea symptoms. Show Less Read more